Bottom line: Rule 701 is the federal securities exemption that lets private companies grant equity compensation — options, restricted stock, RSUs — without SEC registration. Startups blow it in two ways: granting to people who don't qualify, and blowing the rolling 12-month math. Either mistake creates rescission rights that surface at exactly the wrong moment: your financing, acquisition, or IPO. This guide covers both, plus the SEC staff guidance issued March 6, 2026 that changes how you count repriced and forfeited options.
What Rule 701 covers — and what it doesn't
Rule 701 under the Securities Act exempts offers and sales of securities by non-reporting companies under a written compensatory benefit plan or written compensation contract. Three requirements sit in that sentence, and each one matters:
Non-reporting issuer. The exemption is unavailable to Exchange Act reporting companies. Once you're public, you use Form S-8.
Written plan or contract. The grant must be made under a written equity incentive plan or a written compensation agreement. Handshake grants don't qualify.
Compensatory purpose. Rule 701 covers equity issued to compensate for services. It cannot be used to raise capital. This boundary drives the eligibility rules below.
Who can receive Rule 701 equity
Rule 701(c) limits eligible recipients to: (1) employees; (2) directors; (3) general partners; and (4) consultants and advisors who are natural persons providing bona fide services not connected to capital raising. (Officers, business-trust trustees, and family members who receive securities by gift or domestic relations order are also covered, but in a typical startup those follow from the first four.)
The first three categories are straightforward. The fourth is where startups consistently get into trouble, in three recurring ways.
Natural persons only. You cannot issue Rule 701 equity to a consulting firm, a contractor LLC, or an agency. If your fractional CFO bills through an LLC, the LLC cannot take the grant — only the individual performing the services can. If the entity insists on holding the equity, you need a different exemption, typically Regulation D.
The capital-raising exclusion. Anyone whose services involve soliciting investors, promoting the sale of securities, or otherwise assisting with fundraising is excluded — even if fundraising is only part of their role. This is the advisory-board trap: an advisor who gives genuine product guidance but whose real value is investor introductions does not qualify. The legitimate advisory work doesn't cure the capital-raising component.
Bona fide services. The SEC looks at whether services are actually performed, not at titles. Advisory boards assembled for pitch-deck optics, options granted to a landlord for reduced rent, equity to a vendor for a discount — none of these are compensatory grants for services, and none qualify.
A grant outside these categories is not a paperwork foot-fault. It is an unregistered sale of securities without an exemption, and it carries rescission rights: the recipient can demand their money back — leverage that tends to get exercised when your company becomes worth suing over.
Former employees: the at-the-time-of-offer trap
A question that comes up more than you'd expect: the company wants to reward someone who already left — additional vesting, a new grant, a thank-you award that was never promised while they worked there. Rule 701 usually can't do it. The rule exempts offers and sales to former employees, directors, consultants, and advisors only if they were employed by or providing services to the issuer at the time the securities were offered. The operative fact is when the offer was made. A discretionary award conceived after someone's last day is an offer made to a non-service-provider, and it falls outside the exemption. (The SEC proposed in 2020 to permit offers to former employees for services performed within 12 months before separation; that proposal was never adopted.)
What still works. Post-termination exercise of vested options granted during employment is fine — the offer was made while they worked there, and the exemption travels with the original grant. And if the former employee still holds unvested restricted stock subject to a repurchase right, the company can waive that right as to some or all of the shares — effectively vesting them — without any new offer or sale at all, because the shares were sold during employment. That waiver is the cleanest way to deliver the economics. Tax follows the 83(b) fork: with a timely election on file, the waiver is a tax non-event; without one, the fair market value of the newly freed shares is W-2 ordinary income at lapse, with withholding, ex-employee or not.
What doesn't. Unvested options typically terminate by their terms at separation. "Restoring" or extending vesting on a lapsed award is economically a new grant — a new offer to a former employee — and the staff's March 2026 position that a repricing is a new sale cuts firmly against treating substantive post-termination modifications as mere amendments.
The timing lever. All of this flips if the change happens before the last day of service. Amend the award, waive the cliff, accelerate — while the person is still employed, the offer is made during service and Rule 701 covers it. If a departure is coming and the board wants to do something, paper it before the termination is effective, not as a post-exit favor.
If it has to be a new post-termination grant, use a different exemption: Rule 506(b) if the recipient is accredited (certainty, and federal preemption of state registration), or a straight Section 4(a)(2) private placement for a one-off to a sophisticated former employee — a facts-and-circumstances analysis with no safe harbor, so treat it as a single transaction, not a program. Either way, grant it outside the equity incentive plan — most plans limit eligibility to current service providers, so a plan grant to an ex-employee can violate the plan's own terms — and track it on a separate ledger line, the same discipline as entity grants. Pure 4(a)(2) has no state preemption, so pair it with a state transaction exemption where the recipient lives (in Washington, the isolated/nonpublic offering exemption under RCW 21.20.320(1) — the compensatory exemption at RCW 21.20.310(10) tracks Rule 701(c) and fails for the same reason). Or skip the securities analysis entirely and pay cash.
Whatever the structure, it is compensation for past services: ordinary income, W-2 reporting and withholding — for withholding purposes there is no such thing as a former employee whose compensation escapes it (see Tax Withholding on Former Employees) — and a §409A check before anyone signs if the arrangement builds in deferral or payment timing.
The math: the greatest-of-three cap
Rule 701(d) caps what you can sell in any consecutive 12-month period at the greatest of:
1. $1,000,000 in aggregate sales price;
2. 15% of the issuer's total assets, measured at the most recent balance sheet date; or
3. 15% of the outstanding amount of the class of securities being offered, measured in securities, not dollars.
Two mechanics trip people up. First, this is a rolling 12-month test, not a calendar-year test — at every grant, you look backward 12 months. Second, the third prong is measured in number of securities: if 12,000,000 shares of common are outstanding, you can sell up to 1,800,000 shares under that prong regardless of their dollar value, as long as you test consistently.
What each award type consumes:
Options are counted at their aggregate exercise price, on the date of grant. 100,000 options at a $2.00 strike consumes $200,000 of capacity — when granted, not when exercised.
Restricted stock is counted at the price paid, or the value of the securities if issued for services.
RSUs are counted at fair value on the grant date — typically tied to your 409A valuation. Because there's no strike price, RSUs consume capacity roughly twice as fast as options at the same share count. This is the single most common way growth-stage companies silently exhaust their Rule 701 capacity.
A worked example. Total assets $25M; 12M shares of common outstanding; new options priced at a $1.50 strike; RSU fair value $3.00. Your dollar cap is $3.75M (15% of assets — the greatest dollar prong), and your share cap is 1.8M shares. In the trailing 12 months you granted 1M options at $1.50 ($1.5M), 400K RSUs ($1.2M), and 100K restricted shares at $1.50 ($150K) — $2.85M and 1.5M shares consumed. A new 300K RSU grant adds $900K, landing you exactly at the $3.75M dollar cap with 1.8M shares issued — both prongs fully consumed. The next grant needs to wait for the window to roll, a fresh balance sheet, or another exemption.
The $10 million disclosure trigger
Separately from the cap, Rule 701(e) requires enhanced disclosure — the plan, risk factors, and financial statements — once aggregate sales exceed $10 million in any consecutive 12-month period. The disclosure must be delivered a reasonable period before the sale, which for options generally means before exercise. Crossing $10M doesn't prohibit grants; failing to deliver the disclosure before sales occur loses the exemption for the entire offering above the threshold.
The March 2026 SEC guidance: four changes to your tracking
On March 6, 2026, the SEC's Division of Corporation Finance issued new and revised Compliance & Disclosure Interpretations on Rule 701. Four points change how companies should run their ledgers:
1. The $10M disclosure goes to everyone, prospectively. The staff's position is that once an issuer expects sales to exceed $10 million in a 12-month period, the Rule 701(e) disclosure should go to all participants in the offering during that period — not just those who receive grants after the threshold is crossed. Plan for the disclosure before you need it, not after.
2. Repricing counts as a new sale. Repricing underwater options counts as a new sale on the repricing date, included in the rolling 12-month totals for both the cap and the $10M trigger. A broad repricing can consume an enormous amount of capacity in a single day — model it before the board approves it.
3. Cancelled and forfeited options drop out. Options that are forfeited or cancelled no longer count against the Rule 701(d) and (e) limits. If your ledger doesn't back out departures, you're understating your remaining capacity.
4. M&A aggregation for the disclosure trigger. An acquirer assuming a target's derivative securities must count the target's trailing 12-month Rule 701 sales toward its own $10M disclosure threshold. Diligence the target's Rule 701 ledger before closing, not after — the acquisition trap is covered in detail here.
What happens when you get it wrong
The primary consequence is rescission: recipients of non-exempt grants can demand repurchase. In acquisition diligence, buyer's counsel reviews every grant on the cap table against an exemption; a Rule 701 defect gives the buyer leverage on price, escrow, and indemnities — or a reason to walk. Cures exist — rescission offers for recent grants, restructuring or reissuance under Regulation D, and disclosure with reps-and-warranties insurance for historical defects — but every option gets more expensive with time and valuation growth.
The compliance checklist
Maintain one Rule 701 ledger tied to your cap table: every grant dated, valued by award type, tested against a rolling 12-month total in both dollars and shares, with forfeitures backed out. Before any grant to a non-employee, confirm three things: natural person, no capital-raising role, genuine documented services under a written agreement. Model repricings before approving them. And set the $10M disclosure process up the quarter before you expect to need it.
Rule 701 compliance is mostly discipline. The cost of getting it right is a ledger and a review with counsel before non-employee grants. The cost of getting it wrong is priced into your exit.
If you're issuing equity and want your Rule 701 ledger and advisory agreements reviewed before your next financing or exit, schedule a 20-minute call.
This post is for general information and is not legal advice for your specific situation.
